Focus Taiwan App

CORONAVIRUS/Taiwan grants EUA for updated Pfizer and Moderna COVID-19 vaccines

10/26/2022 09:10 PM
To activate the text-to-speech service, please first agree to the privacy policy below.
CNA file photo
CNA file photo

Taipei, Oct. 26 (CNA) Taiwan on Wednesday granted emergency use authorization (EUA) to second-generation COVID-19 vaccines from Pfizer-BioNTech and Moderna, according to the Food and Drug Administration.

Aside from immunity against the original COVID-19 strain, the adapted bivalent vaccines from both brands also target the omicron BA.4 and BA.5 subvariants of the virus.

Central Epidemic Command Center (CECC) head Victor Wang (王必勝) said the CECC planned to procure between 600,000 to 700,000 doses from Moderna, adding the vaccines will likely arrive in November.

(By Shen Pei-yao, Shih Hsiu-chuan and James Lo)


> Chinese Version


Oct. 27: Taiwan shortens interval for children to get COVID boosters

View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.